Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
174.56
161.76
137.99
114.21
103.02
100.63
80.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
174.56
161.76
137.99
114.21
103.02
100.63
80.39
Raw Material Cost
36.96
46.09
29.38
20.94
23.10
28.08
19.52
Purchase of Finished goods
37.87
11.00
27.55
29.06
22.13
22.00
16.63
(Increase) / Decrease In Stocks
-7.81
-0.01
4.43
7.46
-4.53
-2.16
-1.53
Employee Cost
30.66
29.63
21.65
14.63
19.01
14.70
12.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
22.87
25.54
20.82
22.68
17.62
14.74
12.42
Total Expenditure (Excl Depreciation)
120.55
112.25
103.83
94.77
77.33
77.36
59.07
Operating Profit (PBDIT) excl Other Income
54.01
49.51
34.16
19.44
25.69
23.27
21.32
Other Income
3.78
5.41
3.36
11.77
5.16
1.86
0.48
Operating Profit (PBDIT)
57.79
54.92
37.52
31.21
30.85
25.13
21.80
Interest
5.33
6.19
5.04
5.30
6.16
5.27
4.82
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
52.46
48.73
32.48
25.91
24.69
19.86
16.98
Depreciation
7.86
8.09
5.99
5.23
4.20
3.89
3.52
Profit Before Tax
44.60
40.64
26.49
20.68
20.49
15.97
13.46
Tax
11.02
10.52
5.31
2.71
4.06
2.90
2.55
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
33.58
30.12
21.18
17.97
16.43
13.07
10.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
33.58
30.12
21.18
17.97
16.43
13.07
10.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.92
-2.26
1.45
0.14
-0.75
0.23
0.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
31.66
32.38
19.73
17.83
17.18
12.84
10.73
Equity Capital
46.05
46.05
46.05
46.05
46.05
33.27
33.27
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.88
7.03
4.28
3.87
3.73
3.86
3.23
Diluted Earnings per share
7.29
6.54
4.6
3.81
5.04
3.92
3.39
Operating Profit Margin (Excl OI)
32.76%
32.28%
26.22%
18.54%
24.94%
23.68%
26.82%
Gross Profit Margin
31.82%
31.77%
24.93%
24.71%
23.97%
20.21%
21.36%
PAT Margin
20.37%
19.64%
16.25%
17.14%
15.95%
13.3%
13.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.91% vs 17.23% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -2.22% vs 64.12% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 9.09% vs 44.94% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -13.89% vs 22.82% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Senores Pharma. With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
174.56
450.29
-275.73
-61.23%
Other Operating Income
0.00
0.00
0.00
Total Operating income
174.56
450.29
-275.73
-61.23%
Raw Material Cost
36.96
280.84
-243.88
-86.84%
Purchase of Finished goods
37.87
15.06
22.81
151.46%
(Increase) / Decrease In Stocks
-7.81
-4.08
-3.73
-91.42%
Employee Cost
30.66
43.78
-13.12
-29.97%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
22.87
45.30
-22.43
-49.51%
Total Expenditure (Excl Depreciation)
120.55
380.90
-260.35
-68.35%
Operating Profit (PBDIT) excl Other Income
54.01
69.39
-15.38
-22.16%
Other Income
3.78
1.65
2.13
129.09%
Operating Profit (PBDIT)
57.79
71.04
-13.25
-18.65%
Interest
5.33
3.95
1.38
34.94%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
52.46
67.09
-14.63
-21.81%
Depreciation
7.86
11.42
-3.56
-31.17%
Profit Before Tax
44.60
55.68
-11.08
-19.90%
Tax
11.02
13.53
-2.51
-18.55%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
33.58
42.15
-8.57
-20.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
33.58
42.15
-8.57
-20.33%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.92
0.00
1.92
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.66
42.15
-10.49
-24.89%
Equity Capital
46.05
57.23
-11.18
-19.54%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.88
7.37
-0.49
-6.65%
Diluted Earnings per share
7.29
7.37
-0.08
-1.09%
Operating Profit Margin (Excl OI)
32.76%
15.41%
0.00
17.35%
Gross Profit Margin
31.82%
14.90%
0.00
16.92%
PAT Margin
20.37%
9.36%
0.00
11.01%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 174.56 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 7.91% vs 17.23% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 69.44% vs 30.90% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 31.66 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -2.22% vs 64.12% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 84.28% vs 141.97% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 54.01 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 9.09% vs 44.94% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 110.24% vs 69.57% in Dec 2024
Quarterly - Interest
Interest 5.33 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -13.89% vs 22.82% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -13.47% vs 151.43% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.76%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
